Related Experiment Video
Updated: Nov 10, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Approaching Reactive Arthritis Associated With Poor Prognostic Factors: A Case Report and Literature Review.
Swetha Ann Alexander1, Eunjung Kim2, Ranadeep Mandhadi2
1Internal Medicine, University of Connecticut, Farmington, USA.
Reactive arthritis treatment primarily uses NSAIDs, followed by glucocorticoids or DMARDs. Novel therapies like adalimumab are increasingly used for patients with poor prognostic factors.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Reactive arthritis is an inflammatory condition often triggered by infection.
- Understanding its manifestations and diagnostic challenges is crucial for effective management.
Observation:
- A literature review identified current treatment practices for reactive arthritis.
- Focus was placed on therapies for patients with poor prognostic factors.
Findings:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are the first-line treatment.
- Glucocorticoids and disease-modifying anti-rheumatic drugs (DMARDs) are subsequent options.
- Tumor necrosis factor inhibitors (TNFI), such as adalimumab, are increasingly used for severe cases.
Implications:
- Treatment choice for reactive arthritis depends on prognostic factors.
- Emerging therapies offer new hope for non-responders and severe disease presentations.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Pericarditis III: Medical Management

